The physiological function of the IR-PI3K-AKT pathway is regulating blood glucose levels, and PIK3CA mutations activate the PI3K pathway and fuel cancer by promoting glucose uptake and accelerating glycolytic flux (Fig. 3). This evidence concerns the gene AKT1 and cancer.